Nan Chen,MD: Clinical Trials

1 trial sponsored by Nan Chen,MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Nan Chen,MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rituximab and RASi in Patients with IgAN
Rituximab, RAS 2410 - IgA Nephropathy
Phase 4CompletedNan Chen,MD1162020-07-012025-03-14

Conditions studied

Glomerulonephritis, IGA (1)  ·  Proteinuria (1)

Interventions

Rituximab (1)  ·  resminostat (1)

Countries

China (1)

Top investigators

Jingyuan Xie (1)

Results publications

PMID 38299639